STOCK TITAN
  1. Home
  2. News
  3. ZYXI

Zynex Medical to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

ENGLEWOOD, Colo., May 10, 2022 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that it will participate in two upcoming investor conferences.

Zynex management will be participating virtually in the H.C. Wainwright Annual Global Investment Conference. Interested parties can access the live and archived webcast on the Events section of the website at https://zynexmed.investorroom.com/ir-home on Tuesday, May 24, 2022, at 7am ET.

Zynex management is also scheduled to present at the UBS Global Healthcare Conference on Wednesday, May 25, 2022, at 12:15 PM ET. Interested parties can access the live and archived webcast at https://zynexmed.investorroom.com/ir-home.

About Zynex, Inc.
Zynex, founded in 1996, develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis and laser-based pulse oximetry monitoring systems for use in hospitals. For additional information, please visit: www.zynex.com 

Investor Contact
Gilmartin Group
650 Fifth Ave., Suite 2720
New York, NY 10019
IR@zynex.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/zynex-medical-to-participate-in-upcoming-investor-conferences-301543538.html

SOURCE Zynex

Stock ZYXI logo
ZYNEX INC

NASDAQ:ZYXI

ZYXI Rankings

#3298 Ranked by Market Cap
#3699 Ranked by Stock Gains
N/A Ranked by Dividends

ZYXI Latest News

Apr 30, 2024
Zynex Reports First Quarter 2024 Financial Results
Apr 18, 2024
Zynex Sets First Quarter 2024 Earnings Call
Apr 2, 2024
Zynex Earns Prestigious 2024 Top Workplaces USA Employer Recognition Award
Feb 29, 2024
Zynex Reports Fourth Quarter and Full Year 2023 Financial Results
Feb 22, 2024
Zynex Sets Fourth Quarter and Full Year 2023 Earnings Call

ZYXI Stock Data

351.23M
15.72M
51.14%
31.25%
18%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
ENGLEWOOD

About ZYXI

zynex, inc. founded in 1996, engineers, manufactures and markets neuro-diagnostics, stroke rehabilitation, pain management and cardiac monitoring devices within three subsidiaries. zynex medical is a provider of electrotherapy products for home use. zynex monitoring solutions develops products for cardiac monitoring for use in hospitals. zynex neurodiagnostics develops devices for emg and eeg diagnostic applications within neurology disciplines. zynex medical's product line is fully developed, fda/ce cleared, commercially sold, and has been developed to uphold the company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. zynex monitoring solutions and zynex neurodiagnostics are currently both in the development stages without any significant revenues.